Revisiting the compound muscle action potential (CMAP).
Waveform changes of compound muscle action potential (CMAP) with muscle length.
Quantification of potency of neutralizing antibodies to botulinum toxin using compound muscle action potential (CMAP).
Nerve conduction studies: Basic concepts.
Tavee J.
Handb Clin Neurol. 2019;160:217-224. doi: 10.1016/B978-0-444-64032-1.00014-X.
Far-field potentials in the compound muscle action potential.
Sonoo M.
Muscle Nerve. 2020 Mar;61(3):271-279. doi: 10.1002/mus.26743. Epub 2019 Nov 20.
Compound Muscle Action Potential and Myosin-Loss Pathology in Patients With Critical Illness Myopathy: Correlation and Prognostication.
Shelly S, Soontrapa P, Madigan NN, Polzin MJ, Singh TD, Sista SRS, Paul P, Braksick SA, Liao B, Windebank AJ, Boon AJ, Litchy WJ, Milone M, Liewluck T.
Neurology. 2024 Jul 9;103(1):e209496. doi: 10.1212/WNL.0000000000209496. Epub 2024 Jun 13.
Prior muscle activation affects the compound muscle action potential.
Peterson GW, Tsao BE, Nist LD, Estevez D, Brandstater ME.
Muscle Nerve. 2019 Jul;60(1):25-31. doi: 10.1002/mus.26463. Epub 2019 Mar 25.
Compound muscle action potential (CMAP) scan examination of paretic and contralateral muscles reveals motor unit alterations after stroke.
Chen M, Lu Z, Li X, Zong Y, Xie Q, Li S, Zhou P.
Sci China Life Sci. 2023 Nov;66(11):2604-2613. doi: 10.1007/s11427-022-2308-8. Epub 2023 May 29.
Far-field potential of the compound muscle action potential as a reliable marker in amyotrophic lateral sclerosis.
Higashihara M, Yamazaki H, Izumi Y, Kobayashi M, Nodera H, Oishi C, Iwata A, Murayama S, Kaji R, Sonoo M.
Muscle Nerve. 2023 Sep;68(3):257-263. doi: 10.1002/mus.27829. Epub 2023 Apr 22.
Analysis of the compound muscle action potential scan: Step index (STEPIX) and amplitude index (AMPIX).
Nandedkar SD, Barkhaus PE, Stålberg EV.
Clin Neurophysiol. 2022 Jul;139:119-127. doi: 10.1016/j.clinph.2022.04.011. Epub 2022 Apr 26.
Site-dependent thenar compound muscle action potential: Comparison between surface and needle recordings.
Yue S, Yue Q, Hale T, Knecht A.
J Back Musculoskelet Rehabil. 2019;32(6):841-845. doi: 10.3233/BMR-181188.
Compound muscle action potential duration ratio for differentiation between Charcot-Marie-Tooth disease and CIDP.
Kitaoji T, Noto YI, Kojima Y, Tsuji Y, Kitani-Morii F, Mizuno T, Nakagawa M.
Clin Neurophysiol. 2023 Feb;146:124-130. doi: 10.1016/j.clinph.2022.12.004. Epub 2022 Dec 22.
Changes in phrenic nerve compound muscle action potential in streptozotocin-induced diabetic rats.
Ferrari MC, Peixoto JV, Fogaça RH, Dias FA.
Respir Physiol Neurobiol. 2022 Sep;303:103923. doi: 10.1016/j.resp.2022.103923. Epub 2022 May 30.
